Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Kirchner

Showing results (31-40 of 347) with videos related to

Pageof 35
Sort By:
Nature Reviews. Cancer|September 9, 2005
Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progressionThomas Brabletz, Andreas Jung, Simone Spaderna, et al.
Cancer Treatment Reviews|January 2, 2009
Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFRVolker Heinemann, Sebastian Stintzing, Thomas Kirchner, et al.
The Journal of Investigative Dermatology|December 24, 2005
The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alphaChristina Lohwasser, Daniel Neureiter, Bernd Weigle, et al.
Cancer|August 7, 2009
Invasion associated up-regulation of nuclear factor kappaB target genes in colorectal cancerDavid Horst, Jan Budczies, Thomas Brabletz, et al.
Pathology, Research and Practice|May 16, 2022
AURKA is a prognostic biomarker for good overall survival in stage II colorectal cancer patientsPeter Jung, David Horst, Thomas Kirchner, et al.
Virchows Archiv : an International Journal of Pathology|January 27, 2009
Comprehensive immunohistochemical analysis of Her-2/neu oncoprotein overexpression in breast cancer: HercepTest (Dako) for manual testing and Her-2/neuTest 4B5 (Ventana) for Ventana BenchMark automatic staining system with correlation to results of fluorescence in situ hybridization (FISH)Doris Mayr, Sibylle Heim, Cedric Werhan, et al.
Magnetic Resonance in Medicine|March 4, 2014
Reduction of voxel bleeding in highly accelerated parallel (1) H MRSI by direct control of the spatial response functionThomas Kirchner, Ariane Fillmer, Jeffrey Tsao, et al.
Pathology, Research and Practice|January 11, 2014
Dedifferentiated chondrosarcoma mimicking a giant cell tumor. Is this low grade dedifferentiated chondrosarcoma?Thomas Knösel, Mathias Werner, Andreas Jung, et al.
Pathology, Research and Practice|June 21, 2015
Expression of cancer stem cell markers in metastatic colorectal cancer correlates with liver metastasis, but not with metastasis to the central nervous systemMarlies Michl, Volker Heinemann, Andreas Jung, et al.
Frontiers in Oncology|October 20, 2017
Use of Multicenter Data in a Large Cancer Registry for Evaluation of Outcome and Implementation of Novel ConceptsGabriele Schubert-Fritschle, Stephanie E Combs, Thomas Kirchner, et al.
Pageof 35

Showing results (31-40 of 347) with videos related to

Sort By:
Pageof 35
Nature Reviews. Cancer|September 9, 2005
Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progressionThomas Brabletz, Andreas Jung, Simone Spaderna, et al.
Cancer Treatment Reviews|January 2, 2009
Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFRVolker Heinemann, Sebastian Stintzing, Thomas Kirchner, et al.
The Journal of Investigative Dermatology|December 24, 2005
The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alphaChristina Lohwasser, Daniel Neureiter, Bernd Weigle, et al.
Cancer|August 7, 2009
Invasion associated up-regulation of nuclear factor kappaB target genes in colorectal cancerDavid Horst, Jan Budczies, Thomas Brabletz, et al.
Pathology, Research and Practice|May 16, 2022
AURKA is a prognostic biomarker for good overall survival in stage II colorectal cancer patientsPeter Jung, David Horst, Thomas Kirchner, et al.
Virchows Archiv : an International Journal of Pathology|January 27, 2009
Comprehensive immunohistochemical analysis of Her-2/neu oncoprotein overexpression in breast cancer: HercepTest (Dako) for manual testing and Her-2/neuTest 4B5 (Ventana) for Ventana BenchMark automatic staining system with correlation to results of fluorescence in situ hybridization (FISH)Doris Mayr, Sibylle Heim, Cedric Werhan, et al.
Magnetic Resonance in Medicine|March 4, 2014
Reduction of voxel bleeding in highly accelerated parallel (1) H MRSI by direct control of the spatial response functionThomas Kirchner, Ariane Fillmer, Jeffrey Tsao, et al.
Pathology, Research and Practice|January 11, 2014
Dedifferentiated chondrosarcoma mimicking a giant cell tumor. Is this low grade dedifferentiated chondrosarcoma?Thomas Knösel, Mathias Werner, Andreas Jung, et al.
Pathology, Research and Practice|June 21, 2015
Expression of cancer stem cell markers in metastatic colorectal cancer correlates with liver metastasis, but not with metastasis to the central nervous systemMarlies Michl, Volker Heinemann, Andreas Jung, et al.
Frontiers in Oncology|October 20, 2017
Use of Multicenter Data in a Large Cancer Registry for Evaluation of Outcome and Implementation of Novel ConceptsGabriele Schubert-Fritschle, Stephanie E Combs, Thomas Kirchner, et al.
Pageof 35